GSE25055 Expression Data

W. Fraser Symmans, Stephen Piccolo, Ifeanyichukwu O. Nwosu et al. · Zenodo (CERN European Organization for Nuclear Research) · 2011

Discovery cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer. Neoadjuvant study of 310 HER2-negative breast cancer cases treated with taxane-anthracycline chemotherapy pre-operatively and endocrine therapy if ER-positive. Response was assessed at the end of neoadjuvant treatment and distant-relapse-free survival was followed for at least 3 years post-surgery.

Cited by 0 works. doi:10.5281/zenodo.18123419

Authors